This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. An increasing number of pharma professionals are relying on marketintelligence platforms to stay on top of these movements while providing the tools they need to devise a business or investment strategy.
Within the ever-evolving realm of the life sciences industry , fast-paced healthcare investment research plays a crucial role in providing timely insights on valuable opportunities for financial investors.
To succeed, companies must have the capacity to gather and merge multiple consumer and market data sources. And our 2023 Global Consumer Insight Analytics survey report showcases how marketers across various industries leverage consumer research to promote brand recognition and drive business growth.
DuBell began his career at Kantar as a research analyst in 2007. He led the publishing of an internationally distributed multi-client marketingresearch report for almost four years. At Planet Biotechnology, he supervised a group of research associates and designed DNA constructs for research and production efforts.
And today, we’re proud to say that AlphaSense is the world’s most robust marketintelligence search platform for professionals across all industries. As we look to the future, we’re excited about how we’ll keep our customers ahead of the market through innovations in generative AI (genAI). Our solution?
From billion-dollar funding for research on widespread health adversities to manufacturing new technologies to address them, the virus has ramped up lucrative investment opportunities in nearly every industry sector. Since the onset of the COVID-19 pandemic, the pharma industry has experienced rapid, radical change.
But when it comes to broker research, most professionals today are unaware of the insights these reports hold. In fact, most marketintelligence platforms lack access to this form of intel, not only leaving blind spots in your research, but also a window for you to overlook lucrative market opportunities.
According to a marketintelligence report published by BIS Research, titled ‘ Global NGS Informatics and Clinical Genomics Market – Analysis and Forecast (2018 – 2028) ’, the global market is expected to reach $5885.8 will lead the market with a revenue share of $416.6
Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital.
While the United States manufacturing sector took a hit from COVID-19-spawned disruptions, it is important to note that the industry churns out the goods needed to sustain the needs and wants of the world’s largest consumer market. She spent two years at KLA as marketintelligence manager. As of 2019, there were some 12.8
Department of State (DOS), and commercial clients in the pharmaceutical, financial services and education sectors. Datastrong enhanced Smartronix’s cloud capabilities and expanded solutions in enterprise analytics, data science, and data engineering and management. Datastrong also brought new federal clients within the U.S.
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial marketintelligence to gain a competitive advantage in the shifting landscape. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?
This approach enables providers to gather data about the molecular mechanisms of an individual being tested, which further enables researchers to develop targeted therapies and preventive strategies. The precision therapeutics is segmented into clinical trials, cell therapy, drug discovery and research, and gene therapy.
Regardless of this divergence in opinion, weight loss drugs like Ozempic, Wegovy, and Mounjaro offer a promising opportunity in the healthcare and pharmaceuticalmarket, with innovation and research continually striving to provide safer and more effective solutions for those in need. And the market is just huge.”
And researching older influencers with authentic and relevant pain challenges will be a must for brands. They have the longest laundry list of painful ailments that CBD targets and anything that relieves pain while creating a smaller pharmaceutical footprint for them is a win-win. View this post on Instagram.
For biological medicines, studies have revealed research and development costs at $985 million to bring a single product to market. Research has revealed growing trust among physicians and patients alike with biosimilars thanks to education campaigns and improved regulatory guidance from the Food and Drug Administration. . “As
Expert networks are a critical tool for marketintelligence and are leveraged by professionals to gain firsthand knowledge of specialized industries, companies, and markets. One common misconception is the view that expert perspectives may introduce a potential risk for bias in the research process.
President Biden’s Inflation Reduction Act (IRA) is making history within the pharmaceutical space: for the first time, Medicare will negotiate the prices of prescription drugs. laws had prohibited Medicare from negotiating pharmaceutical prices as part of its prescription drug program that began about 20 years ago.
Although, the vaccine market is small as compared to the pharmaceuticalmarket in the healthcare industry but has showcased a better growth rate than the pharmaceuticalmarket. billion in 2017 and is expected to reach $103.57 billion by 2028, growing at a CAGR of 11% during the forecast period (2018 – 2028).
As ESG investing becomes increasingly important to a company’s vitality in our volatile market, future compliance and audit requirements will likely follow, making digitization essential to scale resources and outcomes organization-wide. timber, natural pharmaceuticals) and services (i.e., AlphaSense is that and more.
Over the past couple of years, research on various types of sophisticated drugs is being carried out for the treatment of a variety of diseases and biologics is one of them. The area of focus for these companies is extensive research and development programs, which can help develop best-in-class therapies for the novel patient experience.
Growing both our customer base and employee presence in Singapore will strengthen this effort even further, especially in such a crucial economy like the Asia-Pacific region, and help us adapt to new circumstances and market shifts more effectively. To support these efforts, we are doubling down on talent recruitment in Singapore.
Contify, an AI-enabled market and competitive intelligence solutions provider, announced today that it has successfully deployed its platform to generate customized daily competitive intelligence reports for a leading pharma company focused on the development of novel drugs to treat rare diseases.
The introduction of technologies such as artificial intelligence and machine learning have transformed several sectors, including the robotics and UAV industry. Research and development activities in robotics undertaken by several organizations have led to the development of new-age robots performing functions better than humans.
Owing to the applications of microbiology testing across various industries, such as pharmaceutical, food and beverage, dairy, agriculture and fermentation, paper, biotechnology, and water & environmental industry, the global industrial microbiology market is projected to witness significant growth during the forecast period, 2019-2028.
According to the latest marketintelligence report by BIS Research titled Global Cancer Immunotherapy Market – Analysis and Forecast (2018-2028), the market was valued at $39.86 billion in 2017 and is expected to witness significant growth at a CAGR of 14.14% during the forecast period (2018-2028), to reach $170.70
Industry nuances, company culture, leadership styles, competitor interactions—these are facets you can’t necessarily uncover by researching numbers and figures, yet they significantly impact whether or not two companies have the right synergies to succeed. Navigating the cultural challenges around M&A integration is a delicate process.
Competitor monitoring transcends industries and equips every kind of business—from startups to global corporations—with the intelligence they need to navigate complex markets and outmaneuver their competition. It’s supported by advanced AI features for added scope, speed, and accuracy—all in one centralized platform.
The point is whether it’s Fauci, Longmire or even Chief Medical Microsoft scientist and researcher, Junaid Bajwa , knowing what healthcare KOLs have to say is extremely beneficial. In fact, they could be hospital executives, health system directors, researchers like Dr Tedros Adhonom Ghebrevesus , patient advocacy group members and more.
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Our Approach to this Analysis: We started by analyzing pharma-sponsored clinical trials, 1 initiated between 2018 and 2022, for only unapproved primary immuno-oncology (IO) drugs.
Under these programs, “prescription drug spending accounts for a significant portion of national pharmaceutical spending, which totaled $577 billion in 2021, and supply-chain complexity has complicated efforts to track the flow of these dollars.” So maybe the PBMs are to blame.
What to Look for in a Competitive Intelligence Tool To find the best competitive intelligence tool for your business, you need to know what to look for and what questions to ask during your research. What artificial intelligence (AI) capabilities does it provide, if any?
This past September, Danish pharmaceutical company Novo Nordisk surpassed LVMH to become the most valuable listed company in Europe due to a surge in demand for its highly efficient diabetes and weight-loss medications, Ozempic and Wegovy. Competition is brewing, setting the stage for a landscape that will rapidly evolve in 2024 and beyond.
AlphaSense, a leading artificial intelligence (AI)-based marketintelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. Similarly, expert calls fill particular roles. If you’re going to force me into TPU, that’s like locking me in.
According to Precedence Research , the AI market within the healthcare sector is projected to surpass $20.6 In silico trials, powered by AI simulations, researchers can forecast the efficacy and safety profiles of new drugs before they reach human trials. billion in 2023.
This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value.
These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their marketresearch, landscaping, and monitoring. Which company provides access to the most in-depth, varied expertise that will ultimately eliminate blind spots in your research?
When conducting marketresearch in the healthcare and pharma sectors, you need access to the right information, as well as a way to separate relevant insights from extraneous noise. Unfortunately, traditional marketresearch is a largely manual, time-consuming process.
Additionally, organizations are discovering the value of advanced artificial intelligence (AI) search capabilities that filter through the noise to extract the most meaningful insights from data to increase the ROI from your research.
Additionally, organizations are discovering the value of advanced artificial intelligence (AI) search capabilities that filter through the noise to extract the most meaningful insights from data to increase the ROI from your research.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content